Refine
Has Fulltext
- yes (297)
Is part of the Bibliography
- yes (297) (remove)
Year of publication
Document Type
- Journal article (297) (remove)
Keywords
- Infektionsbiologie (57)
- Escherichia coli (19)
- Candida albicans (12)
- escherichia coli (11)
- gene expression (10)
- RNA-seq (9)
- Staphylococcus aureus (8)
- expression (8)
- infection (8)
- Biologie (7)
- Immunologie (7)
- virulence (7)
- epithelial cells (6)
- identification (6)
- pathogens (6)
- activation (5)
- antimicrobial resistance (5)
- gene regulation (5)
- messenger RNA (5)
- plasmodium falciparum (5)
- sRNA (5)
- transcriptome (5)
- antibiotics (4)
- antibodies (4)
- antisense RNA (4)
- bacteria (4)
- biofilms (4)
- inhibition (4)
- macrophages (4)
- resistance (4)
- small RNA (4)
- synthesis (4)
- transcriptomics (4)
- vancomycin (4)
- COVID-19 (3)
- Expression (3)
- Hfq (3)
- Legionella pneumophila (3)
- Neisseria meningitidis (3)
- RNA (3)
- RNA sequencing (3)
- RNA-binding proteins (3)
- SARS-CoV-2 (3)
- Salmonella (3)
- adaptation (3)
- antibacterial activity (3)
- autophagy (3)
- bacillus subtilis (3)
- biology (3)
- cancer (3)
- genes (3)
- genome sequence (3)
- leishmania major (3)
- mechanisms (3)
- medicine (3)
- mouse models (3)
- protein kinase (3)
- sequence (3)
- signaling pathway (3)
- staphylococcus aureus (3)
- stem cells (3)
- substituent (3)
- transcription (3)
- transcription factors (3)
- translation (3)
- Agent (2)
- Antisense RNA (2)
- Aspergillus fumigatus (2)
- Breast-tumors (2)
- Campylobacter jejuni (2)
- Cancer (2)
- Candida auris (2)
- DNA transcription (2)
- E. coli serotype 06 (2)
- F8 fimbriae (2)
- Grad-seq (2)
- Growth (2)
- HFQ (2)
- HeLa cells (2)
- Helicobacter pylori (2)
- In-vivo (2)
- Leishmania (2)
- Lung cancer (2)
- MATQ-seq (2)
- MRSA (2)
- Medizin (2)
- NSG (2)
- Nude-mice (2)
- RNA synthesis (2)
- RNS (2)
- Rhodobacter sphaeroides (2)
- SEQ (2)
- Salmonella Typhimurium (2)
- Salmonella enterica (2)
- Salmonella typhimurium (2)
- Salmonellosis (2)
- Streptomyces (2)
- T cells (2)
- Therapy (2)
- adhesion (2)
- allelic replacement (2)
- antibiotic resistance (2)
- antifungals (2)
- antigen (2)
- antisense RNAs (2)
- apoptosis (2)
- archaea (2)
- bacterial genetics (2)
- bioluminescence imaging (2)
- biosynthesis (2)
- chaperone (2)
- comparative genomics (2)
- cytokines (2)
- cytotoxicity (2)
- dRNA-Seq (2)
- enterica serovar typhimurium (2)
- epidemiology (2)
- evolution (2)
- fluorescence microscopy (2)
- gastric cancer (2)
- gastrointestinal tract (2)
- gene (2)
- gene cloning (2)
- gene expression profiling (2)
- genome (2)
- genome annotation (2)
- glycopeptide antibiotics (2)
- hemolysin (2)
- host cells (2)
- humanized mice (2)
- in vitro (2)
- in vivo imaging (2)
- in-vitro (2)
- in-vivo (2)
- inflammation (2)
- inhibitor (2)
- leishmania (2)
- leishmaniasis (2)
- liraglutide (2)
- magnetic resonance imaging (2)
- malaria (2)
- mechanism (2)
- messenger-RNA (2)
- metabolism (2)
- metastasis (2)
- methionine (2)
- mutation (2)
- neuroimmunology (2)
- neutrophils (2)
- noncoding RNA (2)
- obesity (2)
- oncolytic virotherapy (2)
- oncolytic viruses (2)
- parasitic diseases (2)
- pathogenicity (2)
- plants (2)
- polycationic peptides (2)
- protein kinases (2)
- proteins (2)
- recombination (2)
- red fluorescent protein (2)
- regulator (2)
- regulator genes (2)
- regulatory RNA (2)
- response regulator (2)
- responses (2)
- ribonucleases (2)
- riboswitch (2)
- secretion (2)
- secretion systems (2)
- signal transduction (2)
- single-cell RNA-seq (2)
- small RNAs (2)
- small nucleolar RNAs (2)
- strains (2)
- structure-activity (2)
- subunit (2)
- therapy (2)
- transmission (2)
- transmission electron microscopy (2)
- tumors (2)
- type VII secretion system (2)
- vaccinia virus (2)
- virulence factors (2)
- (+)-limonene (1)
- (Nucleotide sequence (1)
- 0 antigen (1)
- 2-component system (1)
- 3D tissue model (1)
- 3′ UTR (1)
- 5-bromodeoxyuridine (1)
- 6S RNA (1)
- AMP-activated kinases (1)
- ATG (1)
- ATG8 (1)
- AcrAB-TolC efflux pump (1)
- Adherence (1)
- Adhesion (1)
- Adhäsion (1)
- Alkyltransferase Ribozyme SAMURI (1)
- Apicomplexan (1)
- Archaea (1)
- Avirulent Salmonella (1)
- BNIP3 (1)
- BT_1884 (1)
- Bacillus subtilis (1)
- Bacterial conjugation (1)
- Bacterial pathogens (1)
- Bacteriaophage AR9 (1)
- Bakterien (1)
- Biology (1)
- Blood-brain barrier (1)
- Bordeiella pertussis (1)
- Bovis (1)
- Bradyrhizobium (1)
- C-6-H (1)
- C-Terminus (1)
- COX-2 (1)
- CRISPR-Cas system (1)
- CRISPRs (1)
- CTSE (1)
- CUL4-DDB1 ubiquitin ligase (1)
- Carcinoma (1)
- Cas9 (1)
- Cell binding (1)
- Chemical modification (1)
- Chemotherapy (1)
- Combination therapy (1)
- Crohns-disease (1)
- CsrA (1)
- Cutaneous leishmaniasis (1)
- Cyclophosphamide (1)
- Cystic-fibriosis (1)
- DASH (1)
- DNA (1)
- DNA glycosation (1)
- DNA lang range mapping (1)
- DNA methylation (1)
- DNA methylferase homolog (1)
- Deletion (1)
- Dextran sulphate (1)
- Diarrhea (1)
- Disease gene prioritization (1)
- Division (1)
- Dual 3'seq (1)
- E. coli hemolysin (1)
- E. coli virulence (1)
- ESAT‐6‐like secretion system (1)
- ESS (1)
- Elektronisches Publizieren (1)
- Enterica serovar typhimurium (1)
- Enterobacteriaceae (1)
- Enterococcus faecalis (1)
- Enterococcus faecium (1)
- Environmental isolate (1)
- Epstein-Barr virus (1)
- Erwachsener (1)
- Erwinia amylovora (1)
- EsaA (1)
- Escherichia coli-Hfq (1)
- Escherichia-coli K-12 (1)
- Ethiopia (1)
- Evasionsmechanismen (1)
- Evolution (1)
- Excision (1)
- F-19 MRI (1)
- F1 (1)
- Family (1)
- Fimbria (1)
- Fimbriae (1)
- FinO family (1)
- Foc protein (1)
- Ftsz (1)
- GFP (1)
- GI-101A tumor xenografts (1)
- GLP-1 (1)
- GLV-1 h153 (1)
- GLV-1H68 (1)
- GO1 (1)
- Gene (1)
- Gene cloning (1)
- Gene expression (1)
- Gene mapping (1)
- Gene regulation (1)
- Gene-expression (1)
- Gene-transfer (1)
- Genetik (1)
- Genome analysis (1)
- Genome re-annotation (1)
- Genomic profile (1)
- Germany (1)
- GibS (1)
- Gifsy-1 (1)
- Gram-positive bacteria (1)
- Haemolysin (1)
- Haloferax volcanii (1)
- Harnwegsinfekt (1)
- Helicobacterpylori (1)
- Hemolysin excretion (1)
- Hirnhautentzündung (1)
- Homology (1)
- Hospital water system (1)
- Host adaptation (1)
- Host cells (1)
- Hämolysin (1)
- IL-12 production (1)
- IcaR (1)
- Ileal Crohns-disease (1)
- Images (1)
- Immunsystem (1)
- In-vitro (1)
- Inactivation (1)
- Infection (1)
- Inflammation (1)
- Inhibitor (1)
- Internal transcription start site (1)
- Invasion genes (1)
- Ire1 (1)
- Iron-oxide (1)
- Iron-uptake (1)
- IsrK (1)
- K279a (1)
- KhpB protein (1)
- Klebsiella pneumoniae (1)
- Krebs <Medizin> (1)
- Langerhans cell (1)
- Leaderless transcript (1)
- Legionella ssp. (1)
- Legionellae (1)
- Leishmania major (1)
- Leishmanien (1)
- Lesions (1)
- Level (1)
- Listeria monocytogenes (1)
- Lungenkrebs (1)
- Lysis (medicine) (1)
- MACE (1)
- MI-2/NURD complex (1)
- MRI reporter (1)
- MRSA - methicillin-resistant Staphylococcus aureus (1)
- MTOR (1)
- MVT (1)
- Macrophage (1)
- Maintenance (1)
- Makrophagen (1)
- Malaria (1)
- Malignant effusion (1)
- Medicine (1)
- Methanosarcina mazei (1)
- Mice (1)
- MicroRNAs (1)
- Mig1 (1)
- Minor subunits (1)
- Molekulare Infektionsbiologie (1)
- Mouse (1)
- Mutant (1)
- Mycobacterium (1)
- N-glycans (1)
- NAFLD (1)
- NAS (1)
- NASH (1)
- ND10 complex (1)
- NF-KAPPA-B (1)
- NK cells (1)
- NOTCH (1)
- NRG1 (1)
- NSG-SGM3 (1)
- Neugeborenes (1)
- Nodule (1)
- Non-coding RNAs (1)
- Nonpathogenic Escherichia-coli (1)
- OLFM4 (1)
- Oncolytic virotherapy (1)
- One Health (1)
- Organoids (1)
- Orthogonal field attenuation gel electrophoresis (1)
- OxyR (1)
- P-fimbriae (1)
- P. falciparum (1)
- PCR (1)
- PEGylation (1)
- PETRI-seq (1)
- PFS25 (1)
- PIA/ica (1)
- PML (1)
- PML nuclear-bodies (1)
- PPGPP (1)
- PSI-blast (1)
- PYY3-36 (1)
- Paeonia (1)
- Pan1 (1)
- Parkinson's disease (1)
- Particles (1)
- Pathogenicity (1)
- Pathogens (1)
- PfAMA1 (1)
- PfCCp protein (1)
- Pfs230 (1)
- Pilus (1)
- PknB (1)
- Plasmid (1)
- ProQ (1)
- Promoter (1)
- Promoter prediction (1)
- Protein (1)
- Protein function prediction (1)
- Proteins (1)
- Proteogenomics (1)
- Proteomanalyse (1)
- Pseudomonas (1)
- Pseudomonas aeruginosa (1)
- Pseudomonas-aeruginosa (1)
- RFP (1)
- RNA CHAPERONE HFQ (1)
- RNA chaperone Hfq (1)
- RNA denaturation (1)
- RNA expression (1)
- RNA sequence analyses (1)
- RNA structure (1)
- RNA-Seq (1)
- RNA-polymerase-I (1)
- RNA-polymerase-II (1)
- RNA-sequencing (1)
- RNAseq (1)
- RNase E (1)
- RNase III (1)
- ROS (1)
- RTS,S/AS01 malaria vaccine (1)
- RYGB (1)
- Rapid evolution (1)
- Rats (1)
- Recombinant vaccinia (1)
- Recombination directionality factor (1)
- Regression (1)
- Ribosome profiling (1)
- Roux-en-Y gastric bypass surgery (1)
- S fimbrial adhesin (Sfa) (1)
- S-Fimbriae (1)
- S-fimbria (1)
- S-fimbriae (1)
- S. aureus (1)
- SER/THR kinase (1)
- SM-like protein (1)
- SNF1 (1)
- SUBSP carotovora (1)
- SWI2/SNF2-like protein (1)
- Salmonella enterica Typhimurium strain SL1344 (1)
- Salmonella-enteritidis (1)
- Salmonella-typhimurium (1)
- Schistosoma japonicum; Egg antigen; Carbohydrate epitope; Circumoval precipitin test; Immunoassay (1)
- SdsR (1)
- Sequence identity (1)
- Sequencing (1)
- Serogroup (1)
- Serratia marcescens (1)
- Shiga toxin-producing Escherichia coli (1)
- Shigella (1)
- Shigellosis (1)
- Site-specific RNA labelling (1)
- Snf1 (1)
- Soft-tissue infection (1)
- Southern hybridization (1)
- Speichel (1)
- Staphylococcal infection (1)
- Staphylococcus aureus USA300 (1)
- Staphylococcus aureus immune response (1)
- Staphylococcus-aureus (1)
- Stenotrophomonas maltophilia (1)
- Stp (1)
- Strain nissle-1917 (1)
- Strains (1)
- Sugar-transport (1)
- Suicide vector (1)
- SuperSAGE (1)
- T cell (1)
- T helper cell (1)
- T lymphocytes (1)
- T-Zellen (1)
- T-cell (1)
- TEM (1)
- TRNA(ASP) (1)
- Tissue (1)
- Toll-like receptors (1)
- Toxicity ; plasmids (1)
- Toxoplasma gondii (1)
- TraDIS (1)
- Tracking (1)
- Transcription (1)
- Transcription profiling (1)
- Transcription start site (1)
- Transcriptome (1)
- Transcriptome analysis (1)
- Transfer-RNA modification (1)
- Translation efficiency (1)
- Transposon insertion sequencing (1)
- Typhimurium (1)
- UKZ (1)
- UME6 (1)
- Urinary tract (1)
- Uropatbcgenie E. coli (1)
- VEGF (1)
- Vaccinia virus (1)
- Valeriana wallichii (1)
- Variability (1)
- Variants (1)
- Vascular endothelial Growth Factor (1)
- Virologie (1)
- Virulence (1)
- Virusinfektion (1)
- WD40 (1)
- Yersinia (1)
- Yersinia-pseudotuberculosis (1)
- YoelII-Nigeriensis (1)
- Ypk1 (1)
- abscesses (1)
- acetivorans C2A (1)
- acetones (1)
- acid (1)
- acrican trypanosomes (1)
- actinomycetes (1)
- activation mechanism (1)
- acute myeloid leukemia (1)
- adaptation phase (1)
- adults (1)
- agroinfiltration (1)
- alignment (1)
- alignment clustering (1)
- alpha defensins (1)
- alternative pig farming (1)
- alveolar fibrosis (1)
- alveolar regeneration (1)
- animal model (1)
- animal models (1)
- animal-model (1)
- annotation (1)
- anti-biofilm (1)
- anti-schistosomal activity (1)
- anti-sigma factor (1)
- antibacterial (1)
- antibacterial drug resistance (1)
- antibacterials (1)
- antibiotic (1)
- antibiotic production (1)
- antifungal drug (1)
- antigen-presenting cells (1)
- antigenic variation (1)
- antimicrobial activity (1)
- antimicrobial peptides (1)
- antimicrobials (1)
- antitermination (1)
- arabidopsis (1)
- aspergillosis (1)
- aspergillus fumigatus (1)
- atypical tetracyclines (1)
- autophagy-related (1)
- azobenzenes (1)
- bacterial biofilms (1)
- bacterial genomes (1)
- bacterial genomics (1)
- bacterial immune evasion (1)
- bacterial infection (1)
- bacterial infection model (1)
- bacterial lipoproteins (1)
- bacterial migration (1)
- bacterial pathogen (1)
- bacterial physiology (1)
- bacterial resistance (1)
- bacterial secretion (1)
- bacterial signal molecule (1)
- bacterial transcription (1)
- bacterial virulence (1)
- bacteriology (1)
- bacteriophage (1)
- balancing selection (1)
- beta-glucuronidase (1)
- beta-lactamases (1)
- binding (1)
- binding protein HFQ (1)
- biocide polyhexamethylene biguanide (1)
- biofilm (1)
- biofilm regulation (1)
- biolog (1)
- biological scaffold (1)
- bioluminescence (1)
- bioorthogonal SAM analogue ProSeDMA (1)
- biophotonic imaging (1)
- biosynthetic gene-cluster (1)
- blood (1)
- blood-brain barrier (1)
- blood-cerebrospinal fluid barrier (1)
- blood-stream forms (1)
- brain endothelial cells (1)
- breast-tumors (1)
- broad-spectrum antibiotics (1)
- burkholderia cenocepacia (1)
- caffeic acid bornyl ester (1)
- campestris PV vesicatoria (1)
- campylobacter (1)
- cancer microenvironment (1)
- cancer treatment (1)
- cancers and neoplasms (1)
- candida albicans (1)
- carbon metabolism (1)
- carcinoma (1)
- carcinomas (1)
- carvacrol (1)
- casposon (1)
- catalytic (1)
- cell cultures (1)
- cell cycle (1)
- cell death (1)
- cell differentiation (1)
- cell fusion (1)
- cell signalling (1)
- cell vaccines (1)
- cell wall (1)
- cell wall synthesis (1)
- cell-cycle arrest (1)
- cell-line (1)
- cepedia complex (1)
- chaperone HFQ (1)
- chaperone Hfq (1)
- characterization (1)
- chelocardins (1)
- children (1)
- chlamydomonas flagella (1)
- chromosomal genes (1)
- citral (1)
- citrus (1)
- clinical (1)
- clinical isolates (1)
- clonal analysis (1)
- coagulase-negative staphylococci (1)
- cold-shock protein (1)
- coli nissel 1917 (1)
- colony morphotypes (1)
- colorectal (1)
- colorectal cancer (1)
- community settings (1)
- comparative sequence analysis (1)
- complete genome sequence (1)
- complex (1)
- components (1)
- conditional mutants (1)
- conditional promoter replacement (1)
- conservation (1)
- conserving surgery (1)
- consesus (1)
- contact lens (1)
- controllability (1)
- cost-effectiveness (1)
- crystal structure (1)
- crystal-structures (1)
- cytolethal distending toxin (1)
- dRNA-seq (1)
- dark-matter (1)
- database (1)
- decay (1)
- deep sequencing (1)
- deepSuperSAGE (1)
- deficient mice (1)
- deletion mutagenesis (1)
- dendritic cells (1)
- dependent gene-expression (1)
- dependent protein-kinase (1)
- derivatives (1)
- determines pathgenicity (1)
- diarrhea (1)
- differential (1)
- directional RNA-Seq (1)
- disease (1)
- diseases of the nervous system (1)
- dogs (1)
- domain (1)
- domain genes A3(2) (1)
- down regulation (1)
- drospophila (1)
- drug design (1)
- drug repurposing (1)
- drug resistance evolution (1)
- drug-delivery systems (1)
- dual function (1)
- dynamic programming (1)
- eigenvector centrality (1)
- electron tomography (1)
- electrophilic stress (1)
- elements (1)
- emotional behavior (1)
- emulsions (1)
- endocytosis (1)
- endoribonuclease (1)
- energy metabolism (1)
- enteric pathogens (1)
- enterica serovar thphimurium (1)
- enterobacteria (1)
- enterococci (1)
- environment (1)
- environmental regulation (1)
- enzyme APOBEC3G (1)
- enzyme-linked immunoassays (1)
- ephitelial cells (1)
- epithelial-mesenchymal transition (1)
- epithelium (1)
- escherichia coli K-12 (1)
- essential genes (1)
- essential oils (1)
- ethanol (1)
- eugenyl cinnamate (1)
- eukaryotes (1)
- evasion mechanisms (1)
- experimental visceral leishmaniasis (1)
- expression mutants (1)
- extracellular domain (1)
- extracellular enzymes (1)
- extraintestinal E. coli (1)
- extraintestinal isolates (1)
- extrapulmonary (1)
- falciparum (1)
- family (1)
- fatty acids (1)
- fibronectin-binding protein (1)
- filamentous Salmonella Typhimurium (1)
- finder using symmetrical best hits (1)
- flagellar basal body (1)
- flagellum (1)
- flotillin (1)
- flow cytometry (1)
- fluconazole resistance (1)
- fluorescence imaging (1)
- fluorescent probe (1)
- fluorescent protein (1)
- flux balance analysis (1)
- food industry (1)
- fostamatinib (1)
- functional genomics (1)
- fungal genetics (1)
- fungal pathogens (1)
- fungi (1)
- gallotannins (1)
- gamete (1)
- gametes (1)
- gametocyte (1)
- gastric bypass (1)
- gastrointestinal infections (1)
- gene expression heterogeneity (1)
- gene family targeting (1)
- gene probes (1)
- gene therapy (1)
- gene-cloning (1)
- gene-cluster (1)
- gene-expression (1)
- general stress response (1)
- genetic organization (1)
- genetic recombination (1)
- genetic transcription (1)
- genome wide (1)
- genome-wide analysis (1)
- genomes (1)
- genomic deletions (1)
- genomic islands (1)
- genomic libraries (1)
- genomic library construction (1)
- genomics (1)
- genus Aspergillus (1)
- geometry (1)
- germination (1)
- global gene expression (1)
- glv-1h68 (1)
- glycolysis (1)
- glycosome (1)
- glycosyl phosphatidyl-inostitols. (1)
- gram-negative bacteria (1)
- green fluorescent protein (1)
- growth (1)
- growth rate control (1)
- haemoproteus-columbae (1)
- halstedii JM8 (1)
- harmonia axyridis (1)
- harmonine (1)
- hela cells (1)
- hemolytic-uremic syndrome (1)
- heterogeneity (1)
- heterologous production (1)
- heteropathogenicity (1)
- hexose transporter (1)
- hidden markov-models (1)
- histidine kinases (1)
- histology (1)
- homologs (1)
- homology search (1)
- horizontal gene transfer (1)
- hos tcells (1)
- host (1)
- host (organism) (1)
- host pathogen interaction (1)
- host-cell invasion (1)
- human herpesvirus 6 (1)
- human macrophages (1)
- human pathogenic fungi (1)
- human pathogens (1)
- human sodium iodide symporter (hNIS) (1)
- humanized hemato-lymphoid mice (1)
- hydrogen regulation (1)
- hydrogen-peroxide (1)
- hyperexpression techniques (1)
- hypersensitive response (1)
- hyperthermophile (1)
- hyphae (1)
- hypothalamic gene expression (1)
- immune System (1)
- immune response (1)
- immunity (1)
- immunization (1)
- immunodeficiency-virus type-1 (1)
- in vivo (1)
- in-vitro propagation (1)
- inactivation (1)
- infectious disease (1)
- inflammatory-bowel-disease (1)
- inhibitors (1)
- insect immunity (1)
- insights (1)
- integration (1)
- interaction surfaces (1)
- interactome (1)
- interferon-gamma (1)
- intermediate host (1)
- internalization (1)
- intervention strategies (1)
- interview (1)
- intestinal enteroids (1)
- intracellular pathogen (1)
- intracellular pathogens (1)
- invasion (1)
- iron limitation (1)
- island (1)
- isolation (1)
- kingdom (1)
- latency (1)
- lead structure (1)
- leaves (1)
- legionella pneumophila (1)
- libraries (1)
- library screening (1)
- life cycle (1)
- lines (1)
- linker influence (1)
- lipids (1)
- liquid chromatography-mass spectrometry (1)
- listeria monocytogenes (1)
- livestock-associated staphylococci (1)
- locus (1)
- luciferase (1)
- lux (1)
- lymph nodes (1)
- lymphadenitis (1)
- lytic replication (1)
- mC (1)
- mCherry (1)
- macrophage infection (1)
- malaria parasite (1)
- malaria vaccine (1)
- maps (1)
- marine sponges (1)
- mass spectrometry (1)
- mastectomy (1)
- maternal separation (1)
- mating (1)
- maturation (1)
- mechanism of resistance (1)
- mechanisms of disease (1)
- membrane (1)
- membrane proteins (1)
- membrane vesicles (1)
- membrane-protein topology (1)
- meningococcus (1)
- merozoite (1)
- messanger RNA (1)
- messenger-RNA decay (1)
- meta-analysis based orthology (1)
- metabolic adaptation (1)
- metastases (1)
- methanoarchaea (1)
- methanol methyltransferase isozymes (1)
- methanosarcina mazei GO1 (1)
- methicillin (1)
- miRNAs (1)
- microRNAs (1)
- microSPLiT (1)
- microbiology (1)
- microbiome (1)
- microenvironment (1)
- microneme (1)
- microtubule motor (1)
- mitochondria (1)
- model (1)
- modulation of virus replication (1)
- molecular epidemiology (1)
- molecular evolution (1)
- monocyte (1)
- morphogenesis (1)
- mouse (1)
- mucosal inflammation (1)
- multidrug-resistant bacteria (1)
- multivesicular tubule (1)
- mycobacterium tuberculosis (1)
- mycobacterium-tuberculosis (1)
- myelin biology and repair (1)
- myeloma (1)
- natively unstructured protein (1)
- natural antisense transcripts (1)
- natural transformation (1)
- ncRNA (1)
- necrosis-factor-alpha (1)
- neisseria gonorrhoeae (1)
- network biology (1)
- non-aureus staphylococci (1)
- noncoding RNAs (1)
- nondocing RNA (1)
- northern blotting (1)
- nosocomial pathogen (1)
- nucleotide sequence (1)
- nude-mice (1)
- nutrients (1)
- olfactomedin 4 (1)
- oligopeptides (1)
- oncolytic viral therapy (1)
- oncolytic virus (1)
- one-health approach (1)
- organic farming (1)
- organization (1)
- organohalide respiration (1)
- organoids (1)
- origin (1)
- orthology (1)
- orthology network (1)
- outbreak (1)
- outer-membrane proteins (1)
- oviedomycin (1)
- oxidative stress (1)
- pangolin (1)
- par-seqFISH (1)
- parallel evolution (1)
- parasexual recombination (1)
- parasite (1)
- parasitology (1)
- paromomycin (1)
- pathogen (1)
- pathogenesis (1)
- pathogenetic organism (1)
- pathogenic bacteria (1)
- pathogenicity island 2 (1)
- peptide conjugates (1)
- peptide tyrosine tyrosine (PYY) (1)
- peptide tyrosine tyrosine 3-36 (PYY\(_{3-36}\)) (1)
- peptido-glycan associated protein (1)
- permease (1)
- persistence (1)
- persister cells (1)
- phage (1)
- phagocytes (1)
- pharmacokinetics (1)
- phased metamorphosis (1)
- phenotypic heterogeneity (1)
- phenotypic microarray (1)
- pheromones (1)
- phosphorylation (1)
- photooxidative stress (1)
- photosynthesis genes (1)
- phototrophic growth (1)
- phylogenetic analysis (1)
- phylogenetic trees (1)
- phylogeny (1)
- phytochemicals (1)
- pig farming methods (1)
- plant-made vaccines (1)
- plant-microbe interaction (1)
- plasmid-chromosome crosstalk (1)
- plasmodium (1)
- plastid targeting (1)
- platelet (1)
- point mutation (1)
- polyadenylation sites (1)
- polycistronic transcription (1)
- polymerase chain reaction (PCR) (1)
- porphyromonas gingivalis (1)
- positive selection (1)
- post-transcriptional regulation (1)
- post-transcriptionalregulation (1)
- posttranscriptional control (1)
- ppl (1)
- pre-messenger RNA (1)
- promastigotes (1)
- promoters (1)
- prophage (1)
- proteasome (1)
- protein (1)
- protein HFQ (1)
- protein expressions (1)
- protein families database (1)
- protein kinase signaling cascade (1)
- protein synthesis (1)
- protein-RNA recognition (1)
- protozoan parasite (1)
- pseudomas aeruginosa (1)
- pulmonary (1)
- purification (1)
- pyrococcus furiosus (1)
- quanititative proteomics (1)
- quinone (1)
- rRNA depletion (1)
- radiation-therapy (1)
- radioiodine therapy (1)
- ralstonia solanacearum (1)
- rat (1)
- receptor (1)
- receptors (1)
- reciprocal best hit (1)
- recombinant proteins (1)
- regionalization and organoids (1)
- regulation (1)
- regulatory small RNAs (1)
- remote sequence conservation (1)
- replication (1)
- reporter (1)
- reporter genes (1)
- repression (1)
- reputation (1)
- resistance mechanism (1)
- resistance-breaking properties (1)
- resistant Staphylococcus-aureus (1)
- reveals (1)
- rhodobacter sphaeroides (1)
- ribosomal RNA (1)
- sRNA atlas (1)
- sRNA biogenesis (1)
- salmonella enterica (1)
- sationary phase (1)
- scaffold protein (1)
- schistosoma (1)
- schistosomula (1)
- scholarly publishing (1)
- scientific publishing (1)
- secondary structure (1)
- segmentation (1)
- sequence motif analysis (1)
- sequences (1)
- sequencing protocol (1)
- serotonin (1)
- serovar Typhimurium (1)
- serum resistance (1)
- sexual stage (1)
- sfaA gene) (1)
- shiga toxin (1)
- shock sigma factor (1)
- siRNAs (1)
- signal-transduction systems (1)
- signaling network (1)
- simultaneous (1)
- singlet oxygen stress (1)
- sinorhizobium fredii NGR234 (1)
- skin fatty acid (1)
- small interfering RNAs (1)
- small non-coding RNAs (1)
- small noncoding RNAs (1)
- small regulatory RNAs (1)
- sodium-iodide symporter (1)
- solubility (1)
- soluble-RNA (1)
- soluble-RNAs (1)
- sortase A (1)
- specificity (1)
- spores (1)
- stability (1)
- stage-i (1)
- staib agar (1)
- staphilococci (1)
- staphylocccal infection/epidemiology (1)
- staphylococcal abscess (1)
- staphylococcus (1)
- stationary phase (1)
- stomach (1)
- strain (1)
- strain Newman (1)
- streptococcus pneumoniae (1)
- stress resistance (1)
- stress response (1)
- stringency (1)
- structural elucidation (1)
- structural modification (1)
- structure activity (1)
- structure-activity relationship (1)
- structure–activity (1)
- subcellular localization (1)
- subpopulation (1)
- subtilis genome (1)
- sulfates (1)
- sulfur (1)
- suppressor mutation (1)
- surgery (1)
- synthetase (1)
- tag based (1)
- tandem mass-spectra (1)
- target (1)
- target recognition (1)
- tetrachloroethene (1)
- thymyl cinnamate (1)
- thyroid-cancer (1)
- tobacco (1)
- toll-like receptor 2 (1)
- topical treatment (1)
- toxin (1)
- trans-activation (1)
- transcription factor (1)
- transcription initiation site (1)
- transcription start site (1)
- transcription start sites (1)
- transcriptional control (1)
- transcriptional landscape (1)
- transcriptional regulation (1)
- transcriptional regulator (1)
- transcriptional start site (1)
- transcriptional uni (1)
- transcriptome analysis (1)
- transcriptomeanalysis (1)
- transfer RNA (1)
- translation initiation (1)
- translational initiation (1)
- translocation (1)
- transport systems (1)
- transposable elements (1)
- transposition (1)
- tuberculosis (1)
- two-component systems (1)
- two‐component system (1)
- type III protein secretion system complex (1)
- type III secretion system pathways (1)
- tyrosine kinase (1)
- ubiquitin (1)
- ulcreative colitis (1)
- untranslated regions (1)
- urinary tract infection (1)
- urinary tract infection (UTI) (1)
- urinary-tract-infection (1)
- uropathogenic Escherichia coli (1)
- uropathogenicity (1)
- uropathogens (1)
- vaccines (1)
- vacuoles (1)
- variant surface glycoprotein (1)
- version control (1)
- vibrio parahaemolyticus (1)
- viral protein-R (1)
- viral replication (1)
- virotherapy (1)
- virulence genes (1)
- virulence modulation (1)
- virus-infection (1)
- visceral leishmaniasis (1)
- wikis (1)
- xanthomonas (1)
- xanthomonas campestris (1)
- xanthomonas maltophilia (1)
- yvcK/glmR operon (1)
- zinc cluster transcription factor (1)
- zoonotic (1)
Institute
- Institut für Molekulare Infektionsbiologie (297) (remove)
Sonstige beteiligte Institutionen
- Genelux Corporation, San Diego Science Center, 3030 Bunker Hill Street, Suite 310, San Diego, California 92109, USA (1)
- Institut für Molekulare Infektionsbiologie (MIB) der Universität Würzburg (1)
- MRB Forschungszentrum für Magnet-Resonanz-Bayern e.V., Am Hubland, D-97074 Würzburg (1)
- Research Center for Infectious Diseases (ZINF), University of Wuerzburg, Wuerzburg, Germany, (1)
- Research Center of Infectious Diseases (ZINF) of the University of Wurzburg, Germany (1)
Recently we have described the molecular cloning of the genetic determinant coding for the S-fimbrial adhesin (Sfa), a sialic acid-recognizing pilus frequently found among extraintestinal Eschenchili coli isolates. Fimbriae from the resulting Sfa + E. coli K-12 clone were isolated, and an Sfa-specific antiserum was prepared. Western blots indicate that S fimbriae isolated from different uropathogenic and meningitis-associated E. coli strains, including 083:Kl isolates, were serologically related. The Sfa-specific antibodies did not cross-react with P fimbriae, but did cross-react with FlC fimbriae. Furthermore the sja+ recombinant DNAs and some cloned s/a-flanking regions were used as probes in Southem experiments. Chromosomal DNAs isolated from 018:Kl and 083:Kl meningitis strains with and without S fimbriae and from uropathogenic 06:K + strains were hybridized against these sfa-specific probes. Only one copy of the sfa determinant was identified on the chromosome of these strains. No sfa-specific sequences were observed on the chromosome of E. coli K-12 strains and an 07:Kl isolate. With the exception of small alterations in the sfa-coding region the genetic determinants for S fimbriae were identical in uropathogenic 06:K + and meningitis 018:Kl and 083:Kl strains. The sfa determinant was also detected on the chromosome of Kl isolates with an Sfa-negative phenotype, and specific cross-hybridization signals were visible after blotting against FlC-specific DNA. In addition homology among the different strains was observed in the sfa-flanking regions.
The virulence of the uropathogenic E. coli strain 536 (06: K 1 5: H31) which produces the S-fimbrial adhesin (Sfa•), is serum-resistant (Sre+) and hemolytic (Hiy+) and its derivatives were assessed in five different animal models. Cloned hemolysin (h/y) determinants from the Chromosomes of 06,018 and 075 E. colistrains and from the plasmid pHiy152 were introduced into the spontaneaus Sfa-, Sre-, Hly- mutant 536-21 and its Sfa+, Sre+, Hly- variant 536-31. As already demonstrated for the 536-21 strains {lnfect. Immun. 42: 57-63) the 018-hly determinant but not the plasmid-encoded hly determinant of pHiy 1 52 transformed into 536-31 contribute to lethality in a mouse peritonitis modal. Similar results were obtained with both Hlyhost strains and their Hly+ transformants in a chicken embryo test and in a mouse nephropathogenicity assay in which the renal bacterial counts were measured 1 5 min to 8 hours after i.v. infection. S-fimbriae and serum resistance had only a marginal influence in these three in vivo systems. ln centrast all three factors, S-fimbriae, serum resistance and hemolysin, were necessary for full virulence in a respiratory mouse infection assay. ln a subcutaneously-induced sepsis model in the mouse restoration of S-fimbriae and serum resistance and separately chromosomally-encoded hemolysis increased virulence to a Ievel comparable to that of the parental 536 strain.
Purified S fimbriae and an Escherichia coli strain carrying the recombinant plasmid pANN801-4 that encodes S fimbriae were tested for adhesion to frozen sections of human kidney. The fimbrlae and the bacteria bound to the same tissue domains, and in both cases the binding was specifically inhibited by the receptor analog of S fimbria, sialyl(a2-3)1actose. S fimbriae bound specifically to the epithelial elements in the kidneys; to the epithelial cells of proximal and distal tubules as weil as of the collecting ducts and to the visceral and parietal glomerular epithelium. In addition, they bound to the vascular endothelium of glomerull and of the renal Interstitium. No blnding to connective tissue elements was observed. The results suggest that the biological functlon of S fimbriae is to mediate the adheslon of E. coli to human epithelial and vascular endothellal ceUs.
The hemolytic, uropathogenic Escherichia coli 536 (06:K15:H31) contains two inserts in its chromosome (insert I and insert II), both of which carried hly genes, were rather unstable, and were deleted spontaneously with a frequen~y of 10-3 to 10-4• These inserts were not found in the chromosome of two nonhemolytic E. coli strains, whereas the chromosomal ~equences adjacent to these inserts appeared tobe again homologous in the uropathogenic and two other E. coü strains. Insert I was 75 kilobases in size and was ftanked at both ends by 16 base pairs (bp) (TTCGACTCCTGTGATC) which were arranged in direct orientation. For insert I it was demonstrated that deletion occurred by recombination between the two 16-bp ftanking sequences, since mutants lacking this insert still carried a single copy of the 16-bp sequence in the chromosome. 8oth inserts contained a functional hemolysin determinant. However, the loss of the inserts not only atfected the hemolytic phenotype bot led to a considerable reduction in serum resistance and the loss of mannose-resistant hemagglutination, caused by the presence of S-type funbriae (sja). lt is shown that the Sfa-negative phenotype is due to a block in transcription of the sfa genes. Mutants of strain 536 which lacked both inserts were entirely avirulent when tested in several animal model systems.
The genetic determinant coding for the Pspecific F8 fimbriae was cloned from · the chromosome of the Escherichia coli wild-type strain 2980 (018: K5: H5: FlC, F8). The F8 determinant was further subcloned into the Pstl site of pBR322 and a restriction map was established. In a Southern hybridization experiment identity between the chromosomally encoded F8 determinant of 2980 and its cloned Counterpart was demonstrated. The cloned F8 fimbriäe and those of the wild type strain consist of a protein subunit of nearly 20 kDa. F8 fimbriated strains were agglutinated by an F8 polyclonal antiserum, caused mannose-resistant hemagglutination and attached to human uroepi thellal cells. The cloned F8 determinant was weil expressed in a variety of host strains.
Characterization of a monoclonal antibody against the fimbrial F8 antigen of Escherichia coli
(1986)
A monoclonal lgG 1 antibody against F8 fimbriae was obtained with the hybridoma technique using spieen cells from C3H/f rnice immunised with a fimbrial preparation of Escherichia coli 2980 (018ac: K5: H-: FIC, F8) and Sp 2/0 Ag8 myeloma cells. The hybrid cells were cloned twice by lirniting dilution and grown in tissue culture. The monoclonal antibody was purified from culture supernatants on Protein A Sepharose. lt reacted with F8 fimbriae in colony blot, enzyme-linked immunosorbent assay (ELISA) and immunoblot after electrotransfer from sodium dodecyl sulphate-polyacrylarnide gel electrophoresis (SOS-PAGE) of fimbrial preparations. The antibody bound to and agglutinated F8-fimbriated bacteria.
The haemolysin (hly) determinant of the plasmid pHly152 contains an IS2 element at 469 bp upstream of the hlyC gene. The sequence at the other (right-hand) end (RS) also shows multiple hybridization with the plasmid pHly152 and the chromosome of some Escherichia coli strains but the nucleotide sequence of this region does not reveal the typical properties of an IS element. Similar arrangements in the regions flanking the hly determinant are also found on various Hly plasmids from uropathogenic E. coli strains. Chromosomal hly determinants Iack both flanking sequences (IS2 and RS) in the immediate vicinity of the hly genes. The sequences immediately upstream of the hlyC gene have been determined from several chromosomal hly determinants and compared with the corresponding sequence of the hly determinant of the plasmid pHly152. We show that these sequences, which contain one promoter (left promoter, phlyL) in all hly determinants tested, vary considerably although common sequence elements can still be identified. In contrast, only relatively few nucleotide exchanges have been detected in the adjacent structural hlyC genes. The A + T content of the 200 bp sequence upstream of hlyC is very high (72 mol% A + T) but even the structural hly genes show a considerably higher A + T content (about 60 mol%) than the E. coli chromosome on average (50 mol% A+T) suggesting that the hly determinant may not have originated in E. coli.
We investigated the role of bacterial adherence and hemolysin production from Escherichia coli parent and genetically cloned strains as to their eft'ects on bistaJidne release from rat mast cells and leukotriene generation from human polymorphonuclear granulocytes. These mediators were involved in the induction of inftammatory disease processes and led, for example, to enhancement of vascular permeability, chemotaxis (leukotriene 84 [LTB4]), chemoaggregation, lysosomal enzyme release, and smooth muscle contraction, (LTC4, LTD4 , and LTE4). Washed bacteria (E. coli K-12 Ms+ my=; E. coli 536 Ms+ MR= my=) as weil as their culture supematants were analyzed. Washed E. coli K-12 (Hiy+), unlike Hly- strains, induced high amounts of histamine release from rat mast cells and chemotactic activity from human polymorphonuclear granulocytes. Significant leukotriene releasewas obtained with washed E. coli K-12 my+ strains and their bacterial culture supematants. Leukotriene induction was dependent on the amount of hemolysin activity present in the supematant. However, additional soluble factors should also be considered. The presence of hemolysin appeared to aceeierate and enhance the rate of phagocytosis of bacteria by neutrophUs. When E. coli 536 (MS+ MR= Hly=) strains were analyzed, the simultaneous presence of MR+ pili and hemolysin production led to an increase in histamine release as compared with MR- my+ strains. The genetically cloned MR+ my+ E. coli 536 strain induced higher amounts of IeukotrieDes as compared with the wUd-type strain. Our data soggest a potent role for adhesins and hemolysin as virulence factors in inducing the release of inftammatory mediators.
The Qropathogenic Escherichia coli strain 536 (06:K15:H31) exhibits a mannose-resistant hemagglutination phenotype (Mrh) with bovine erythrocytes and delayed Mrh with human and guinea pig erythrocytes. Neuraminidase treatment of the erythrocytes abolishes mannose resistant hemagglutination, which is typical for X fimbriae. E. coli strain 536 synthesizes two different fimbriae (Fim phenotype) prQtein subunits, 16.5 and 22 kilodaltons in size. In addition the strain shows mannose-sensitive hemagglutination and common type I (Fl) fimbriae. The cosmid clone E. coli K-12(pANN801) and another nine independently isolated Mrh+ cosmid clones derived from a cosmid gene bank of strain 536 express the 16.5-kilodalton protein band, bot not the 22-kilodalton protein, indicating an association of the Mrh+ property with the "16.5-kilodalton fimbriae." All cosmid clones were fimbriated, and they reacted with antiserum produced against Mrh+ fimbriae of the E. coli strain HB101(pANN801) and lacked mannose-sensitive hemagglutination (Fl) funbriae. From the Mrh fim cosmid DNA pANN801, several subclones coding for hemagglutination and X fimbriae were constructed. Subclones that express both hemagglutination and fimbriae and subclones that only code for the hemagglutination antigen were isolated; subclones that only produce fimbriae were not detected. By transposon Tn5 mutagenesis we demonstrated that about 6.5 kilobases of DNA is required for the Mrh+ Fim+ phenotype, and the 1.5- to 2-kilobase DNA region coding for the structural proteiil of the fimbriae has been mapped adjacent to the region responsible for the Mrh+ phenotype. Two different regions can thus be distinguished in the adhesion determinant, one coding for hemagglutination and the other coding for fimbria formation. Transformation of plasmid DNA from these subclones into a Mrh- Fim- mutant of E. coli 536 and into a galE (rough) strain of Salmonella typhimurium yielded transformants that expressed both hemagglutination and fimbria production.
Potential virulence, as defined by combined Ievels of adhesion to urinary epithelial cells, serum resistance, and mouse toxicity, was assessed for Escherichia coli strains causing symptomatic and asymptomatic urinary tract infections in relation to the carriage of hemolysin and other suspected virulence determinants. Hemolysin production (Hly), associated with certain 0 (04, 06, 018, and 075), K (5), and hemagglutination (VI and VII) antigenic types but not colicin V production (Cva), was evident in 83 and 60% ofisolates in groups possessing high potential virulence andin only 11 and 6% of those with low virulence. Strains of particular 0-types were not more virulent per se, but among the serotypes, specific combinations of virulence factors appeared decisive, e.g., 018 HAVI B/D/G Hly+ K5+t- and 018 HAIIIIIVBN Hly- Cva +t- Kl +t- strains were, respectively, of high and low potential virulence. Isolates with high potential virulence were found to a similar extent in symptomatic and asymptomatic infections.
After intraperitoneal injection of mice with Escherichia coli strains isolated from patients with urinary tract infections, the mortality due to hemolytic (Hly+) and nonhemolytic (Hiy-) isolates was 77 and 40%, respectively. Deletion of the chromosomal hemolysin (h/y) determinant in an E. co/i 06:K15:H31 urinary tract infection strain led to a significant reduction in toxicity for mice, and its reintroduction on a recombinant plasmid partially restored the original toxicity. Although introduction of the cloned plasmid pHiy152-encoded hly determinant into the Hly- E. coli 06 mutant strain increased toxicity by only a marginal degree, transformation with the cloned chromosomal hly determinants from two E. coli strains of serotypes 018ac:K5:H- and 075:K95:H? resulted in markedly greater toxicity, even exceeding that of the original Hly+ E. coli 06 wild-type strain.
Evidence for T cell recognition in mice of a purified lipophosphoglycan from Leishmania major
(1989)
We have previously reported that a Leishmania major lipophosphoglycan (LPG), given with killed Corynebacterium parvum as an adjuvant, can vaccinate mice against cutaneous leishmaniasis. In order to analyze whetber T cells are able to recognize this important parasite antigen, we have studied both humoral and cellular immune responses to L. major LPG that bad been isolated from promastigotes by sequential solvent extraction and bydrophobic chromatography. The data sbow that immunization of mice with highly purified LPG induced an increase in frequency of L. major-reactive T cells and the production of immunoglobulin G antibodies to LPG. Furthermore, genetically resistant mice infected with L. major were able to develop a specific delayed-type hypersensitivity response in the ear to L. major LPG. These findings strongly suggest that T cells can recognize and respond to glycolipid antigens, in this case a bost-protective Leishmania LPG, even though such antigens appear not to be potent T-cell stimulators in mice.
In this study we report that cloned Thy-l +, L3T4-, Lyt-l-, Lyt-2+, H-Y-specific and H-2Db-restricted cytotoxic T ce11 lines (CTLL) when indueed by lectin or antigen secrete a soluble mediator(s) (SF) that inhibits proliferation and generation of cytotoxic lymphocytes (CTL) in mixed lymphocyte cultures (MLC). The biological activity was separable by gel filtration and appeared as a broad peak in the moleeular mass range between 10000 and 50000 kDa. It was found that the suppressive activity released by CTLL neither strictly correlates with their cytotoxic potential nor with their ability to produce immune interferon or Iymphotoxin. SF was shown to elicitits activity in an antigen-nonspeeific manner in that it suppressed the maturation of T lymphocytes responding to both, the appropriate H-Y antigen as weH as to unrelated H_2d alloantigens or to the hapten 2,4,6-trinitrophenyl (TNP). The effect of SF on CTL responses was most pronounced in early phases of primary or secondary MLC. When analyzed for its inhibitory activity on precursor ceHs in populations selected for either Lyt-2- or L3T4- lymphocytes, it was found that SF interfered with the maturation of both subsets. The inhibition of CTL responses elicited by SF could not be reversed by the addition of exogenous interleukin 2. The findtng that SF also inhi. bited the proliferation of some but not a11 antigen-dependent cloned T ceHs with helper or eytc'toxic potential provides evidence that the faetor also may regulate effector lymphl)cytes. In addition, the results support the assumption that SF exerts its effect direetly on the responder rather than the stimulator population, and demonstrate that the development of CTL from their preeursor eeHs is contro11ed at least in part by the eytotoxic effeetor cells themselves via a soluble factor(s) that interferes with distinct stages of T ce11 maturation. These findings again emphasize the expression of multiple functions by CTL and indieate their possible role du ring the course of an immune response by their capability to eliminate target cells and to secrete a soluble product(s) that mediates feedback contro!.
We have previously shown that during an infection with Leishmania major, susceptible BALB/c mice, as opposed to mice of a resistant strain (C57BLl6), are primed by lipopolysaccharide for the production of high levels of tumor necrosis factor-\(\alpha\) (TNF-\(\alpha\)) which is known to be a potent maerophage M\(\Phi\) stimulator in other parasitic diseases. In the present study we investigated whether TNF-\(\alpha\) activates M\(\Phi\) for killing of L. major parasites. In the absence of interferon-y (IFN-\(\gamma\)) or lipopolysaccharide, TNF-\(\alpha\) (0.025-25000 U/ml) failed to activate peritoneal exudate M\(\Phi\) from BALB/c mice for killling of L. major amastigotes. In the presence of suboptimal doses of IFN-\(\gamma\) (5 or 10 Vlml), however, TNF-\(\alpha\) mediated a rapid elimination of intracellular parasites, which was highly significant compared to IFN-\(\gamma\) alone. Tbe combination of TNF with interleukin 4, in contrast, was inactive in this respect and allowed survival of intracellular parasites. From these data we conelude that the presence of IFN-\(\gamma\) is crucial for TNF-\(\alpha\)-mediated killing of L. major parasites by M\(\Phi\). Disease progression in susceptible mice therefore seems to be a consequence of a deficiency of IFN-\(\gamma\) and a predominance of interleukin 4 rather than the result of an excess amount of TNF-\(\alpha\).
Syngeneic memory cells can be stimulated to yield a secondary immune response after their transfer into irradiated euthymie recipients as well as into young thymusless nude mice. It is shown that nude mice older than twelve weeks of age are not permissive towards memory cell activation as it is found in non-irradiated euthymie animals. This barrier to isogeneie or congeneic cells seems to be caused by a pool of cyclophosphamide-sensitive cells. Since young nude mice could be rendered as unpermissive as older nude mice by pretreatment with either PNA-agglutinable thymus cells or nylon-wool passed spleen cells, it is suggested that an increased number of precursor T cells in older nude mice might induce this effect. Further experiments with monoclonal antibodies against the Lyt-l, Lyt-2, and L3T4 marker on T cells indicate that T -helper/inducer activity might be required to establish the "isogeneie barrief" in nude mice.
A novel technique for independent and simultaneous labeling of two antigens expressed on individual cells (referred to as mixed labeling) is presented. The staining procedure combined three-step (streptavidin-biotin) immunogold-silver staining with three-step immunoenzymatic labeling. To ensure both high specificity and high sensitivity, particular emphasis was placed on designing a protocol that avoids immunological crossreactivity between the antibody reagents and overlapping of the final color products. Two examples for usage of this mixed labeling technique are described: lymphocyte subpopulations were identified in inflammatory lesions of human skin and infected host cells were characterized in the skin of mice infected with the obligatory intracellular parasite Leishmania major, a cause of human cutaneous leishmaniasis.
Cutaneous leishmaniasis is initiated by the bite of an infected sandfly and inoculation of Leishmania major parasites into the mammalian skin. Macrophages are known to playa central role in the course of infection because they are the prime host cells and funetion as antigen-presenting eells (APC) for induetion of the eell-mediated immune response. However, in addition to maerophages in the dermis. the skin eontains epidermal Langerhans eells (LC) which ean present antigen (Ag) to T cells. Therefore, using a murine model of cutaneous leishmaniasis, we analyzed the ability of epidermal cells to induce a T eell response to L.major. The results demonstrated that freshly isolated LC, but not cuItured LC, are highly active in presenting L.major Ag in vitro to T cells from primed mice and to a L.major-specific T cell clone. Furthermore, freshly isolated LC had the ability to retain L.major Ag in immunogenic form for at least 2 days. Their efficiency was much greater than that of irradiated spleen cells, a standard population of APC. LC stimulated both T cell proliferation and production of the Iymphokines interleukin (IL)-2 and IL-4. The response was Ag specific and could be induced by lysate of L. major parasites and by live organisms. The data suggest that epidermal LC are important APC in eutaneous leishmaniasis. They may perform a critical funetion by eapturing L.major Ag in the skin and presenting it either to quiescent T eells circulating through the draining lymph node or locally to T effector cells infiltrating the cutaneous lesion.
Murine epidermal Langerhans cells (LC) have been demonstrated to stimulate a vigorous T cell response to Leishmania major, a cause of human cutaneous leishmaniasis. It was therefore of interest to analyze whether LC can take up viable parasites. Epidermal cells were obtained from mouse ear skin for incubation with L. major and subsequent detection of intracellular parasites by cytochemistry. Freshly isolated LC, but not cultured LC, phagocytosed L. major and the uptake was inhibited by antibodies to the complement receptor type 3. Electron microscopic studies revealed the presence of viable amastigotes within Le. Moreover, with double-Iabeling techniques, L. major-containing LC could also be detected in infected skin. The results demonstrate that LC can internalize L. major. Since the number of organisms per infected LC remained consistently low, the prime task of LC may not be the promotion of parasite spreading but the presentation of L. major antigen to T cells and, thus, the regulation of the cellular immunity during cutaneous leishmaniasis.
Freshly isolated human T lymphocytes were tested for their response to mycobacteria, mycobacteriallysates, 2 dimensional (2D) PAGE separated mycobacteriallysates, leishmania and defined leishmanial antigen preparations. While,o T cells proliferated vigourously in the presence of mycobacteria and mycobacteria derived lysates, a significant stimulation from 2 D gel separated lysates was not detected. In addition '10 T cells failed to respond towards leishmania or leishmanial components. In the ab T cell compartment some donors, presumably according to their state of immunity against mycobacteria, responded to mycobacteria, mycobacterial lysates and 2 D gel separated mycobacterial lysates. Neither freshly isolated '10 T cells nor ab T cells from naive donors did mount a significant immune response against leishmania.
While clear evidence exists for the direct involvement of cytolysins in the pathogenesis of Gram-positive bacteria, the significance of Gram-negative haemolysins remains unclear. This paper presents briefly data indicating a role for haemolysin production in infections caused by Escherichia coli and also experiments which have allowed an analysis of the molecular basis of the haemolysis among pathogenic and non-pathogenic strains of this species.
During a study of the nutritional requirements of clinical isolates of Escherichia coli, we found that 21 (7.0%) of 301 strains required nicotinamide to grow in minimal medium. The nicotinamide- requiring strains were present in 16 (15.8%) of 101 cultures of urine from young women with acute cystitis, in 5 (5.0%) of 100 stool specimens from healthy adults, and in none of 100 blood samples from adult patients with bacteremia. Most of the strains belonged to serogroup OI8:KI:H7, were hemolytic, possessed type I fimbriae, and exhibited similar patterns of antibiotic susceptibility. Two of the urinary isolates expressed S fimbriae, and all 16 urinary isolates contained the s/aS homologue gene on their chromosomes. One of the stool isolates contained the s/aS gene. The urinary isolates closely resembled a large clone of E. coli that is reportedly associated with neonatal meningitis and sepsis. It may be possible to detect this and related clones by their requirement for nicotinamide and to screen strains for S fimbriae by relatively inexpensive hemagglutination methods, including the use of avian PI antigens to detect mannose- resistant, non-P-fimbriated E. coli; the agglutination of bovine erythrocytes; and the use of bovine mucin to detect sialyl galactosides in S fimbriae.
Over a period of 3 years, Legionella pneumophila serogroup 6 strains were isolated from warm water outlets and dental units in the Dental Faculty and from the Surgery and Internal Medicine Clinics at the University of Dresden, Dresden, Germany. In the bacteriological unit of the above-mentioned facility, L. pneumophila serogroups 3 and 12 were grown frl,)m warm water specimens. The medical facilities are located in separate buildings connected with a ring pipe warm water system. All L. pneumophila serogroup 6 strains isolated from the warm water supply reacted with a serogroup-specific monoclonal antibody, but not with two other monoclonal antibodies which are subgroup specific, reacting with other serogroup 6 strains. The NolI genomic profiles obtained by pulsed-field gel electrophoresis of 25 serogroup 6 strains isolated from the Dental Faculty over a 3-year period, 1 isolate from the Internal Medicine Clinic, and 4 strains from the Surgery Clinic were identical. Furthermore, all these strains hybridized with a 3OO-kb NolI fragment when a legiolysin (lIy)-specific DNA probe was used. The NolI pattern, however, differed from those of six serogroup 6 strains of other origins, one serogroup 12 strain from the bacteriological unit, and another six unrelated strains of serogroups other than serogroup 6. L. pneumophila serogroup 6 strains which can be divided into only two subgroups by the use of monoclonal antibodies are differentiated in at least six Noli cleavage types obtained by pulsed-field electrophoresis.
F 1 C fimbriae allow uropathogenic Escherichia coli to adhere to specific epithelial surfaces. This adhesive property is probably due to the presence of minor fimbrial components in F1C fimbriae. The foe gene cluster encoding F1C fimbriae has been cloned, as described previously. Here we present the nucleotide sequence (2081 bp) coding for the F 1 C minor fimbria I subunits. The structural genes code for polypeptides of 175 (FocF), 166 (FocG), and 300 (FocH) amino acids. The deduced amino acids of the F 1 C minor subunits were compared with the reported sequences of the minor subunits of other types of fimbriae. The data show that the Foc minor subunits are highly homologous to the corresponding Sfa proteins, whereas homology to the minor subunits of type 1 and P fimbriae is much lower.
Die MHK-Werte von Desacetylcefotaxim gegen verschiedene, z. T. ampicillinresistente Stämme von Escherichia coH, die mit Hilfe einer Agardilutionsmethode erhoben wurden, waren höher als die von Cefotaxim und Ceftriaxon, jedoch niedriger als die von Cefoxitin. In einem Modell der systemischen Infektion der Maus mit einem plasmidtragenden, betalactamaseproduzierenden Stamm von E. coli führte die Therapie mit Desacetylcefotaxim zu einer starken Reduktion der Keime pro Leber. Im Vergleich zur Therapie mit Cefotaxim trat die protektive Wirkung aber verlangsamt ein. Desacetylcefotaxim ist also kein unnützes Abbauprodukt von Cefotaxim.
Results of molecular and pathogenic studies of three different bacterial hemolysins (cytolysins) are presented. These exoproteins derive from the two gram-negative bacteria Escherichia coli and Aeromonas hydrophila and from the gram-positive pathogen Listeria monocytogenes. The hemolysin of E. coli is determined by an 8-kilobase (kb) region that includes four clustered genes (hlyC, hlyA, hlyB, and hlyD). This hemolysin determinant is part either of large transmissible plasmids or of the chromosome. The genes located chromosomally are found predominantly in E. coli strains that can cause pyelonephritis and/or other extraintestinal infections. A detailed analysis of the chromosomal hly determinants of one nephropathogenic E. coli strain revealed the existence of specific, large chromosomal insertions 75 kb and lOO kb in size that carry the hly genes but that also influence the expression of other virulence properties, i.e., adhesion and serum resistance. The direct involvement of E. coli hemolysin in virulence could be demonstrated in several model systems. The genetic determinants for hemolysin (cytolysin) formation in , A. hydrophila (aerolysin) and L. monocytogenes (listeriolysin) are less complex. Both cytolysins seem to be encoded by single genes, although two loci (aerB and aerC) that affect the expression and activity of aerolysin have been identified distal and proximal to the structural gene for aerolysin (aerA). Cytolysin-negative mutants of both bacteria were obtained by site-specific deletion and/or transposon mutagenesis. These mutants show a drastic reduction in the virulence of the respective bacteria.
A new mouse model for systemic infection with Escherichia coli is presented. Whereas in other models 107_108 bacteria have to be injected into an animal to induce toxic effects resulting in death within 24 hours, now, only 103_104 bacteria of an appropriate strain are required to produce a genuine infection characterized by an increase in the bacterial load over several days. The quantitative determination of bacterial counts per liver allows a more sensitive measurement than recording death rates. Furthermore, few animals are required for a definite result in contrast to the LDso determination of other models. The salient point regarding this new model is that conditioning of animals has to be achieved by incorporating the inoculum into agar which is injected subcutaneously. The resulting infection is completely dependent on the E. colicondistrain used. Whereas a hemolytic, uropathogenic strain is so virulent that an overwhelming infection develops within 48 hours after the injection of 103 bacterial cells, a non-hemolytic variant of this strain is completely avirulent, being unable to multiply in spite of the potentiating agar. The hemolytic E. coli strain ATCC 25922 is intermediate in virulence. The bacterial counts per liver increase steadily until death occurs five to seven days after the injection of 104 bacteria. This bacterial infection can be therapeutically influenced by daily treatment with various drugs. Ciprofloxacin, ceftriaxone and co-trimoxazole are able to cure the infection, whereas amoxicillin given orally is only moderately active against this ATCC strain, which is relatively resistant to amoxicillin.
Like all other Salmonella typhimurium strains examined, the smooth variants SF1397 (L T2) and 1366 and also their semi-rough and rough derivatives are non-haemolytic. Nevertheless, two haemolysin (Hly) plasmids of E. coli belonging to the inc groups incFllI,lv (pSU316) and incIz (pHly152) were able to be introduced into these strains by conjugation and stably maintained. A considerable percentage of the Hly+ transconjugants obtained had lost parts of their O-side chains, a result of selection for the better recipient capability of « semi-rough» variants rather than the direct influence of the Hly+ plasmids themselves. In contrast to the incF1lI1V plasmid pSU316, which exhibited higher conjugation rates with rough recipients, the incIz plasmid pHly152 was accepted best by smooth strains. Transformation with cloned E. coli haemolysin (hly) determinant was inefficient ( <10-8) for smooth strains, but 102-103 times higher for rough recipients, and was increased by the use of Salmonella-modified DNA. The transform ants and transconjugants were relatively stable and showed the same haemolytic activity as the E. coli donor strains. The virulence of the Hly+ smooth, semi-rough and rough S. typhimurium strains was tested in two mouse models, and neither the mortality rate nor the ability to multiply within the mouse spleen was influenced by the hly determinants.
The 06 serogroup Escherichia coli strain 536 carries two hemolysin (hly) determinants integrated into the chromosome. The two hly determinants are not completely identical, either functionally or structurally, as demonstrated by spontaneous deletion mutants carrying only one of them and by cloning each of the two determinants separately into cosmid vectors. Each hly determinant is independently deleted at a frequency of 10-4 , leading to variants which exhibit similar levels of internal hemolysin but different amounts of secreted hemolysin. The two hly determinants were also identified in the 04 E. coli strain 519. The three E. coli strains 251, 764, and 768, which belong to the serogroup 018, and the 04 strain 367 harbor a single chromosomal hly determinant, as demonstrated by hybridization with hly-gene-specific probes. However, a hybridization probe derived from a sequence adjacent to the hlyC-proximal end of the plasmid pHlyl52-encoded hly determinant hybridizes with several additional chromosomal bands in hemolytic 018 and 06 E. coli strains and even in E. coli K-12. The size ofthe probe causing the multiple hybridization suggests a 1,500- to 1,800-base pair sequence directly flanking hlyC. Spontaneous hemolysin-negative mutants were isolated from strains 764 and 768, which had lost the entire hly determinant but retained all copies of the hlyC-associated sequence. This sequence is not identical to a previously identified (J. Hacker, S. Knapp, and W. Goebel, J. Bacteriol. 154:1145-1154, 1983) somewhat smaller (about 850 base pairs) sequence flanking the other (hlyBb-proximal) end of the plasmid pHlyl52-encoded hly determinant which, as shown here, exists also in multiple copies in these hemolytic E. coli strains and in at least two copies in E. coli K-12. In contrast to the plasmid-encoded hly determinant which is directly flanked at both ends by these two diJJerent sequences, the chromosomal hly determinants are not immediately flanked by such sequences.
The hemolytic Escherichia coli strain 536 (06) propagates spontaneous hemolysin- negative mutants at relatively high rates (10-3 to 10-4 ). One type of mutant (type I) lacks both secreted (external) and periplasmic (internal) hemolysin activity (HlYex - IHlYin -) and in addition shows no mannose-resistant hemagglutination (Mrh -), whereas the other type (type II) is HlYex -IHIYin + and Mrh +. The genetic determinants for hemolysin production (hly) and for mannose-resistant hemagglutination (mrh) of this strain are located on the chromosome. Hybridization experiments with DNA probes specific for various parts of the hly determinant reveal that mutants of type I have lost the total hly determinant, whereas those of type 11 lack only part of the hlyB that is essential for transport of hemolysin across the outer membrane. Using a probe that contains the end sequence of the plasmid pHly152-encoded hly determinant (adjacent to hlyB), we determined that a related sequence flanks also the hlyB-distal end of the chromosomal hly determinant of E. coli 536. In addition several other similar or even identical sequences are found in the vicinity of the hlyC- and the hlyB-distal ends of both the chromosomal and the plasmid hly determinants.
We have cloned the chromosomal hemolysin determinants from Escherichia coli strains belonging to the four O-serotypes 04, 06, 018, and 075, The hemolysin-producing clones were isolated from gene banks of these strains which were constructed by inserting partial Sau3A fragments of chromosomal DNA into the cosmid pJC74. The hemolytic cosmid clones were relatively stable. The inserts were further sub cloned either as Sail fragments in pACYC184 or as BamHI-SaLI fragments in a recombinant plasmid (pANN202) containing cistron C (hlye) of the plasmid-encoded hemolysin determinant. Detailed restriction maps of each of these determinants were constructed, and it was found that, despite sharing overall homology, the determinants exhibited minor specific differences in their structure, These appeared to be restricted to cistron A (hlyA), which is the structural gene for hemolysin. In the gene banks of two of these hemolytic strains, we could also identify clones which carried the genetic determinants for the mannose-resistant hemagglutination antigens Vb and VIc. Both of these fimbrial antigens were expressed in the E. coli K-12 clones to an extent similar to that observed in the wild-type strains. These recombinant cosmids were rather unstable, and, in the absence of selection, segregated at a high frequency.
The role of macrophages in primary and secondary infection of mice with Salmonella typhimurium
(1982)
Elimination of macrophages with high-molecular dextran sulphate (OS) markedly impairs resistance of mice to primary infection with smooth, virulent strains of Salmonella typhimurium, whereas stimulation of this system by killed Bordetella pertussis organisms increases resistance. In infection with rough, avirulent strains of S. iyphimurium the elimination of macro phages was not followed by an essential loss of resistance, and it appears that other non-specific defence mechanisms, for example the complement system, may have compensated for the lack of macrophages. Macrophages, therefore, play an important role in defence during primary infection with virulent strains. In immunity to challenge infection with S. typhimurium, macrophages play an even more significant role. Treatment with OS completely removes immunity, and both humoral and cell-mediated immune mechanisms seem to require the participation of macrophages.
Human B cells appropriately activated by a B cell mitogen are rendered susceptible to human Interleukin 2 (IL-2) as demonstrated with recombinant human IL-2 (rec. h IL-2). They show increased proliferation and drastically enhanced immunoglobulin secretion. Susceptibility to IL-2 is accompanied with the expression of the IL-2 receptor (Tac antigen) on B cells. The data suggest that IL-2 is one of the lymphokines directly involved in the activation of B lymphocytes.
In this study the effect of recombinant human interleukin 2 (rec.hIL-2) on the proliferation and maturation of B lymphocytes was investigated. It was found that the presence of rec.hIL 2 results in proliferation of mitogen (LPS)-activated B cell blasts. In addition, it is shown that highly enriched murine B cells can be induced by rec.hIL-2 to proliferate and to develop into antibody-secreting cells (PFC) in the presence of antigen (SRBC). When tested for its effect on B cell preparations enriched for resting (small) or activated (blasted) B lymphocytes, it was found that rec.hIL 2 provides signals for both B cell populations to develop into PFC. In contrast, induction of proliferation by the same lymphokine source was only seen in blasted B cells. The data indicate that IL 2 is involved in the generation of B effector cells by directly acting on their precursors thereby providing differentiation as well as proliferation signals.
H-Y-specific and H-2Db-restricted, Lyt-1 "2+ T-cell clones (CTLL) with graded specific cytotoxic activities on male C57BL/6 (B6) target cells (1E3, +++; 2C5, ++; 2A5, +, 3E6, ±) were tested for their capacity to inhibit the generation of H-Y-specific cytotoxic T lymphocytes (CTL) in vitro. Addition of irradiated lymphocytes of CTLL 1E3 and CTLL 3E6 but not those of CTLL 2A5 or CTLL 2C5 abolished the generation of CTL from in vivo primed H-Y-specific precursor cells (CTLP) when added to fresh mixed-lymphocyte cultures (MLC). Exogenous sources of T-cell growth factors (TCGF) did not overcome suppression. Rather the presence of TCGF resulted in a further enhancement of suppressive activities in CTLL 1E3 and 3E6 and the induction of similar activities in cells from CTLL 2A5 and 2C5, which by themselves were not inhibitory. Moreover when added to similar MLC on Day 1 instead of Day 0, only irradiated cells of CTLL 3E6 but not those of the other three CTLL were suppressive. Induction of suppressive activities in H-Y-specific CTLL was independent of the appropriate male stimulator cells since it was also observed in MLC induced by irrelevant antigens (H-2, trinitrophenol). Furthermore at low cell numbers, irradiated lymphocytes from any of the CTLL consistently enhanced CTL activities generated from H-Y-specific CTLP. This augmenting activity, which was not TCGF, could be transferred by soluble mediators present in antigen-sensitized CTLL cultures. Thus, these data indicate (i) that cytotoxic effector cells can function as suppressor cells in the generation of CTL, (ii) that the cytotoxic activity of cloned CTL does not correlate with their capacity to suppress CTL responses, (iii) that the inhibition of CTL responses by CTLL is not due to simple consumption of T-cell growth factors produced in MLC, and (iv) that different CTL clones may interfere with the generation of CTL at different stages of their maturation. Moreover, the experiments suggest an antigen-independent enhancement of suppression by the interaction of CTL with lymphokines. Together with the augmenting activity evoked by cloned CTL the data provide strong evidence for the expression of multiple immunological functions by one particular subset of T cells and suggest that cytotoxic effector cells can differentially regulate the maturation and/or clonal expression of their precursor cells.
Mouse H-Y-specific and I-Ab restricted T-cell clones have been established and compared for their helper effects in the differentiation ofboth T and B Iymphocytes. The results demonstrate that three individual T -cell clones and one subclone could help in the antigen-driven induction of cytotoxic Iymphocytes (CTL) from their precursor cells (CTL-P), and were able to activate B cells to develop into antibody-secreting cells (PFC) in the presence of SRBC, provided the cloned T cells were restimulated by H-Y antigen on antigen-presenting cells. In addition, antigen or lectin could induce the same H -Y -specific T -cell clones to secrete factor(s) expressing helper activities similar to that ofthe cloned T cells. Furthermore, it is shown that the T cell-derived soluble mediator(s) was distinct from T-cell growth factor (TCGF) and from immune interferon (lFN-y). The data reveal a new type ofT cell with helper potential for the activation ofCTL-P and B Iymphocytes, and suggest the existence of distinct T helper cells which can provide help for both cytotoxic and antibody responses by virtue of different Iymphokine activities.
We have recently demonstrated that the frequency ofT cells expressing granzyme A is significantly higher in skin lesions and spleens of susceptible BALB/c mice compared with resistant C57BL/6 mice infected with Leishmania major, a cause of human cutaneous leishmaniasis. In the present study, we have performed in vitro studies to characterize the subpopulation, the antigen responsiveness and the lymphokine production pattern of granzyme A-expressing T cells in L. major-infected mice. Using a limiting dilution system for functional analysis of selected T cells at the clonallevel, we could show that granzyme A activity in infected BALB/c mice can be assigned to L. major-reactive CD4\(^+\) T cells secreting interleukin-2 (IL-2) and IL-4. Granzyme A production was most pronounced in the early phase of infection. On the other hand, granzyme A expression could not be detected in C57BL/6-derived T cells responding to L. major. The da ta support the suggestion that granzyme A is produced by L. major-responsive CD4\(^+\) T cells facilitating lesion formation and the dissemination of infection.
The major macromolecule on the surface o/Leishmania majorpromastigotes is a lipophosphoglycan (LPG). This glycoconjugate plays a key role in determining infectivity and survival of para-sites in the mammalian host cell. In addition, L. major LPG is able to induce a host-protective immune response. In this article, we summarise the evidence for recognition of highly purified LPG by T cells and we discuss the potential mechanisms of T-cell Stimulation by this non-protein antigen.
Ten monoclonal antibodies (McAbs) raised to Schistosoma japonicum eggs could be assigned using several serological and immunochemical techniques to 3 groups. The McAbs, termed A, B and C-McAbs, apparently recognize carbohydrate epitopes that can be located on the same antigen molecule. The antibodies, generally of IgM isotype, are idiotypically related. They are distinct from another IgM McAb (Group D-McAb) the carbohydrate target epitope of which can also be associated with the epitopes of A. B and C-McAbs. The McAbs produce large vacuolated bleb reactions in the circumoval precipitin test (COPT) and target epitopes have different representations in various life cycle stages such as immature and mature eggs, male and female worms (including S. mansoni). Antigens affinity purified on columns containing A, B, C and D-McAbs stimulate proliferation of T cells from egg-sensitized mice and elicit DTH reactions in such mice. This raises the possibility that the target antigens of these carbohydrate-reactive monoclonal antibodies are immunopathologic and involved in egg-induced granuloma formation.
Leishmanien besitzen eine Vielzahl von Mechanismen, die humorale und zelluläre Immunabwehr effektiv zu unterlaufen. Diese hängen eng mit der Expression von hauptsächlich zwei Glykokonjugaten auf der Parasitenoberfläche zusammen, dem gp63 und dem Lipophosphoglykan. Die Parasiten sind einerseits schlechte Aktivatoren des alternativen Komplementweges und umgehen damit ihre eigene extrazelluläre Lyse. Oberflächengebundene Komplementfaktoren fördern andererseits die Aufnahme der Leishmanien durch Makrophagen. Solange diese nicht durch T-Zellen aktiviert sind, dienen sie den Parasiten als "Refugium". Dies gilt insbesondere, als Leishmanien in der Lage sind, 1. den "oxidative burst" zu hemmen; 2. toxische Sauerstoffmetaboliten zu entgiften; 3. abbauende lysosomale Enzyme zu hemmen und 4. das saure Milieu in den Lysosomen für ihren eigenen Metabolismus auszunutzen. Schließlich unterlaufen Leishmanien die zelluläre Immunabwehr des Wirts, indem sie die Aktivierung von T-Lymphozyten hemmen und die Expansion von T-Zell-Sub-populationen bewirken, die für ihr eigenes Überleben nützlich sind.